Explore Our Comprehensive Pharmaceuticals Industry Research Reports
P
2023
The global antibody discovery market was valued at $6.9 billion in 2022, and is projected to reach $17.2 billion by 2032, growing at a CAGR of 9.6% from 2023 to 2032.
Report Code : A14913 | Pages : 252 | Category : Life Sciences
P
2023
The global biosimilar monoclonal antibody market was valued at $8.7 billion in 2022, and is projected to reach $64.7 billion by 2032, growing at a CAGR of 22.2% from 2023 to 2032.
Report Code : A03330 | Pages : 293 | Category : Life Sciences
U
2024
Monoclonal antibodies are replicas of a unique parental cell derived from identical immune cells. These antibodies can bind to a particular antigen when administered, as they have monovalent ...
Report Code : A04020 | Category : Life Sciences
P
2023
End Users is projected as the most lucrative segment. The report provides insights based on the key determinants of the market, including drivers and challenges along with their relative impact on the regional and country level.
Report Code : A92226 | Pages : 109 | Category : Life Sciences
P
2023
The U.S. Antibody Discovery Market is expected to expand at a promising compound annual growth rate (CAGR) between 2023 to 2032. The U.S. Antibody Discovery Market growth is attributed to various driving factors and revenue opportunities.
Report Code : A92227 | Pages : 82 | Category : Life Sciences
P
2023
End Users segment is projected to be the dominating segment during the forecast period. The report offers an elaborate analysis on detailed impacts on the Canada Antibody Discovery Market due to the outbreak of COVID-19.
Report Code : A92228 | Pages : 88 | Category : Life Sciences
P
2023
In market End Users, Pharmaceutical and Biotechnology industry holds the largest revenue share during the analysis period and End Users is expected to exhibit the highest CAGR over the analysis period.
Report Code : A92229 | Pages : 71 | Category : Life Sciences
P
2023
Europe Antibody Discovery Market to showcase promising growth throughout the projection period from 2023 and 2032 owing to increased spending from emerging countries.
Report Code : A92230 | Pages : 122 | Category : Life Sciences
P
2023
In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. End Users was the leading segment.
Report Code : A92231 | Pages : 87 | Category : Life Sciences
P
2023
The report focuses on the major industry players operating in the France Antibody Discovery Market and their relative market share. End Users segment dominates the France Antibody Discovery Market and is expected to retain its dominance throughout the forecast period.
Report Code : A92232 | Pages : 80 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.